142 related articles for article (PubMed ID: 1532843)
1. Lack of a role of interleukin 11 in the growth of multiple myeloma.
Paul SR; Barut BA; Bennett F; Cochran MA; Anderson KC
Leuk Res; 1992; 16(3):247-52. PubMed ID: 1532843
[TBL] [Abstract][Full Text] [Related]
2. BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells.
Tanabe O; Kawano M; Tanaka H; Iwato K; Asaoku H; Ishikawa H; Nobuyoshi M; Hirano T; Kishimoto T; Kuramoto A
Am J Hematol; 1989 Aug; 31(4):258-62. PubMed ID: 2787116
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-21 is a growth and survival factor for human myeloma cells.
Brenne AT; Ro TB; Waage A; Sundan A; Borset M; Hjorth-Hansen H
Blood; 2002 May; 99(10):3756-62. PubMed ID: 11986233
[TBL] [Abstract][Full Text] [Related]
4. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.
Klein B; Zhang XG; Jourdan M; Content J; Houssiau F; Aarden L; Piechaczyk M; Bataille R
Blood; 1989 Feb; 73(2):517-26. PubMed ID: 2783861
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma.
Kawano M; Tanaka H; Ishikawa H; Nobuyoshi M; Iwato K; Asaoku H; Tanabe O; Kuramoto A
Blood; 1989 Jun; 73(8):2145-8. PubMed ID: 2786435
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.
Shiao RT; McLeskey SB; Khera SY; Wolfson A; Freter CE
Leuk Lymphoma; 1996 Apr; 21(3-4):293-303. PubMed ID: 8726410
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin 6 in the growth of myeloma-derived cell lines.
Barut BA; Zon LI; Cochran MK; Paul SR; Chauhan D; Mohrbacher A; Fingeroth J; Anderson KC
Leuk Res; 1992 Oct; 16(10):951-9. PubMed ID: 1405708
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-My 1 to 7 established from patients with advanced stage of the disease.
Hitzler JK; Martinez-Valdez H; Bergsagel DB; Minden MD; Messner HA
Blood; 1991 Oct; 78(8):1996-2004. PubMed ID: 1912582
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
[TBL] [Abstract][Full Text] [Related]
11. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.
Kawano M; Hirano T; Matsuda T; Taga T; Horii Y; Iwato K; Asaoku H; Tang B; Tanabe O; Tanaka H
Nature; 1988 Mar; 332(6159):83-5. PubMed ID: 3258060
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
13. Estimation of interleukin 6 production by reverse transcriptase-polymerase chain reaction in four human myeloma cell lines.
Suzuki A; Takahashi T; Okuno Y; Fukumoto M; Fukui H; Koishihara Y; Ohsugi Y; Ohno Y; Imura H
Leuk Res; 1991; 15(11):1043-50. PubMed ID: 1720489
[TBL] [Abstract][Full Text] [Related]
14. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
Takahashi T; Okuno Y; Ohsugi Y
Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
[TBL] [Abstract][Full Text] [Related]
15. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.
Shimizu S; Yoshioka R; Hirose Y; Sugai S; Tachibana J; Konda S
J Exp Med; 1989 Jan; 169(1):339-44. PubMed ID: 2783335
[TBL] [Abstract][Full Text] [Related]
16. Characterization of an interleukin-6-mediated autocrine growth loop in the human multiple myeloma cell line, U266.
Schwab G; Siegall CB; Aarden LA; Neckers LM; Nordan RP
Blood; 1991 Feb; 77(3):587-93. PubMed ID: 1991169
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.
Jernberg H; Pettersson M; Kishimoto T; Nilsson K
Leukemia; 1991 Mar; 5(3):255-65. PubMed ID: 1707469
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells.
Hjorth-Hansen H; Waage A; Börset M
Br J Haematol; 1999 Jul; 106(1):28-34. PubMed ID: 10444159
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
Levy Y; Tsapis A; Brouet JC
J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
[TBL] [Abstract][Full Text] [Related]
20. Cytokines as autocrine growth factors in malignancies.
Kawano M; Kuramoto A; Hirano T; Kishimoto T
Cancer Surv; 1989; 8(4):905-19. PubMed ID: 2701735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
